Variable | All patients (n = 214) | no HAI (n = 158) | HAI (n = 56) | p |
---|---|---|---|---|
Age, years | 63.2 ± 14.7 | 63.3 ± 15.3 | 62.8 ± 13.3 | 0.836 |
Biological sex, male | 158 (73.8) | 113 (71.5) | 45 (80.4) | 0.196 |
GCS on admission | 12.1 ± 2.8 | 12.4 ± 2.6 | 11.5 ± 3.3 | 0.056 |
Transferred from another care facility | 133 (62.1) | 88 (55.7) | 45 (80.4) | 0.001 |
LOS prior to ICU admission (days) | 2.0 (0–30) | 2.0 (0–25) | 4.0 (0–30) | 0.002 |
Charlson Comorbidity Index | 3.37 ± 2.24 | 3.41 ± 2.33 | 3.27 ± 2.02 | 0.682 |
Myocardial Infarction | 20 (8.9) | 15 (9.5) | 5 (8.9) | 0.901 |
Congestive Heart Failure | 26 (11.6) | 23 (14.6) | 3 (5.4) | 0.070 |
Peripheral Vascular Disease | 3 (1.4) | 3 (1.9) | 0 (0.0) | 0.299 |
CVI or TIA | 11 (4.9) | 8 (5.1) | 3 (5.4) | 0.932 |
Dementia | 10 (4.5) | 9 (5.7) | 1 (1.8) | 0.234 |
COPD | 23 (10.3) | 16 (10.1) | 7 (12.5) | 0.622 |
Connective Tissue disease | 11 (4.9) | 9 (5.7) | 2 (3.6) | 0.536 |
Peptic Ulcer Disease | 5 (2.2) | 5 (3.2) | 0 (0.0) | 0.178 |
Liver Disease | 5 (2.2) | 5 (3.2) | 0 (0.0) | 0.178 |
Diabetes Mellitus | 72 (33.1) | 53 (33.5) | 19 (33.9) | 0.958 |
With end-organ damage | 3 (4.2) | |||
Hemiplegia | 7 (3.1) | 6 (3.8) | 1 (1.8) | 0.467 |
Moderate/Severe CKD | 6 (2.7) | 2 (1.3) | 4 (7.1) | 0.022 |
Solid Tumor | 13 (5.8) | 9 (5.7) | 4 (7.1) | 0.697 |
Leukemia | 4 (1.8) | 3 (1.9) | 1 (1.8) | 0.957 |
Lymphoma | 4 (1.8) | 2 (1.3) | 2 (3.6) | 0.274 |
HIV infection | 7 (3.1) | 6 (3.8) | 1 (1.8) | 0.467 |
Invasive Device use | ||||
Urinary Catheter | 124 (57.1) | 70 (44.3) | 54 (96.4) | < 0.001 |
Central Venous Catheter | 61 (28.5) | 20 (12.7) | 41 (73.2) | < 0.001 |
Mechanical Ventilation > 48 h | 124 (57.1) | 68 (43.0) | 56 (100.0) | < 0.001 |
Nasogastric Tube | 29 (13.5) | 11 (7.0) | 18 (32.1) | < 0.001 |
Previous antibiotic use | 164 (77.0) | 109 (68.9) | 55 (98.2) | 0.009 |